Correspondence 0001193125-23-279631 from CERENOME, INC. (PSTV)
CERENOME, INC.
Date: Nov. 17, 2023 · CIK: 0001095981 · Accession: 0001193125-23-279631
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-275531
Letter
PLUS THERAPEUTICS, INC.
4200 Marathon Blvd.
Suite 200
Austin, TX 78756
November 17, 2023
VIA EDGAR
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: Plus Therapeutics, Inc.
Registration Statement on Form S-1 (File No. 333-275531)
Request for Acceleration of Effective Date
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Plus Therapeutics, Inc., a Delaware corporation, hereby requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement on Form S-1 (File No. 333-275531) and declare the Registration Statement effective as of Monday, November 20, 2023, at 9:00 a.m., Eastern time, or as soon as practicable thereafter.
Please contact the undersigned at (210) 974-6913, or David Will of Hogan Lovells US LLP at (212) 918-3785 with any questions. Also, please notify Mr. Will when this request for acceleration has been granted.
Very truly yours,
PLUS THERAPEUTICS, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP PLUS THERAPEUTICS, INC. 4200 Marathon Blvd. Suite 200 Austin, TX 78756 November 17, 2023 VIA EDGAR Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Plus Therapeutics, Inc. Registration Statement on Form S-1 (File No. 333-275531) Request for Acceleration of Effective Date Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Plus Therapeutics, Inc., a Delaware corporation, hereby requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement on Form S-1 (File No. 333-275531) and declare the Registration Statement effective as of Monday, November 20, 2023, at 9:00 a.m., Eastern time, or as soon as practicable thereafter. Please contact the undersigned at (210) 974-6913, or David Will of Hogan Lovells US LLP at (212) 918-3785 with any questions. Also, please notify Mr. Will when this request for acceleration has been granted. Very truly yours, PLUS THERAPEUTICS, INC. By: /s/ Andrew Sims Name: Andrew Sims Title: Chief Financial Officer cc: David Will, Hogan Lovells US LLP